Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suramin and Paclitaxel in Advanced Breast Cancer
NCT00054028Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Dec 2002
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of suramin in breast cancer, sponsored by National Cancer Institute. Started Dec 2002; status: completed.
02
Drugs
suramin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00054028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00054028.